APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cas9 Nuclease

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cas9 Nuclease Industry Growth and Trends Forecast to 2032

28 December 2025114 pages

Choose your research edition.

Industry ResearchCas9 Nuclease Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Cas9 Nuclease Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Cas9 Nuclease Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cas9 Nuclease Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Cas9 Nuclease Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Cas9 Nuclease market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cas9 Nuclease is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cas9 Nuclease is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cas9 Nuclease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cas9 Nuclease include SBS Genetech, Novoprotein, Agilent, Thermo Fisher Scientific, Stemcell Technologies, Sigma-Aldrich, OriGene Technologies, Nippon Gene and New England Biolabs, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cas9 Nuclease market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cas9 Nuclease market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cas9 Nuclease market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cas9 Nuclease.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cas9 Nuclease market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cas9 Nuclease Market by Company

SBS Genetech

Novoprotein

Agilent

Thermo Fisher Scientific

Stemcell Technologies

Sigma-Aldrich

OriGene Technologies

Nippon Gene

New England Biolabs

Kactus

Horizo​​n Discovery

GenScript

Danaher

BPS Bioscience

Applied Biological Materials

Abnova

Cas9 Nuclease Segment by Type

Cas9 mRNA

Cas9 Protein

Cas9 Lentivirus

Cas9 Plasmid

Cas9 Nuclease Segment by Application

Bioagriculture

Gene Therapy

Gene Editing Cell Line Construction

Animal Models

Other

Cas9 Nuclease Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cas9 Nuclease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cas9 Nuclease and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cas9 Nuclease.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cas9 Nuclease manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cas9 Nuclease in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Cas9 mRNA Table 2. Major Company of Cas9 Protein Table 3. Major Company of Cas9 Lentivirus Table 4. Major Company of Cas9 Plasmid Table 5. Global Cas9 Nuclease Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Cas9 Nuclease Sales by Type (2021-2026) & (K Units) Table 7. Global Cas9 Nuclease Sales Market Share in Volume by Type (2021-2026) Table 8. Global Cas9 Nuclease Sales by Type (2021-2026) & (US$ Million) Table 9. Global Cas9 Nuclease Sales Market Share in Value by Type (2021-2026) Table 10. Global Cas9 Nuclease Price by Type (2021-2026) & (US$/Unit) Table 11. Global Cas9 Nuclease Sales by Type (2027-2032) & (K Units) Table 12. Global Cas9 Nuclease Sales Market Share in Volume by Type (2027-2032) Table 13. Global Cas9 Nuclease Sales by Type (2027-2032) & (US$ Million) Table 14. Global Cas9 Nuclease Sales Market Share in Value by Type (2027-2032) Table 15. Global Cas9 Nuclease Price by Type (2027-2032) & (US$/Unit) Table 16. North America Cas9 Nuclease Sales by Type (2021-2026) & (K Units) Table 17. North America Cas9 Nuclease Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Cas9 Nuclease Sales by Type (2021-2026) & (K Units) Table 19. Europe Cas9 Nuclease Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Cas9 Nuclease Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Cas9 Nuclease Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Cas9 Nuclease Sales by Type (2021-2026) & (K Units) Table 23. Latin America Cas9 Nuclease Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Cas9 Nuclease Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Cas9 Nuclease Sales by Type (2021-2026) & (US$ Million) Table 26. Cas9 Nuclease Industry Trends Table 27. Cas9 Nuclease Industry Drivers Table 28. Cas9 Nuclease Industry Opportunities and Challenges Table 29. Cas9 Nuclease Industry Restraints Table 30. Global Cas9 Nuclease Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Cas9 Nuclease Revenue Market Share by Company (2021-2026) Table 32. Global Cas9 Nuclease Sales by Company (2021-2026) & (K Units) Table 33. Global Cas9 Nuclease Sales Share by Company (2021-2026) Table 34. Global Cas9 Nuclease Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Cas9 Nuclease Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Cas9 Nuclease Major Company Production Sites and Headquarters Table 37. Global Cas9 Nuclease Company, Product Type & Application Table 38. Global Cas9 Nuclease Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Cas9 Nuclease by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Cas9 Nuclease Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Cas9 Nuclease Sales by Region (2021-2026) & (K Units) Table 43. Global Cas9 Nuclease Sales Market Share in Volume by Region (2021-2026) Table 44. Global Cas9 Nuclease Sales by Region (2021-2026) & (US$ Million) Table 45. Global Cas9 Nuclease Sales Market Share in Value by Region (2021-2026) Table 46. Global Cas9 Nuclease Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Cas9 Nuclease Sales by Region (2027-2032) & (K Units) Table 48. Global Cas9 Nuclease Sales Market Share in Volume by Region (2027-2032) Table 49. Global Cas9 Nuclease Sales by Region (2027-2032) & (US$ Million) Table 50. Global Cas9 Nuclease Sales Market Share in Value by Region (2027-2032) Table 51. Global Cas9 Nuclease Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Cas9 Nuclease Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Cas9 Nuclease Sales by Application (2021-2026) & (K Units) Table 54. Global Cas9 Nuclease Sales Market Share in Volume by Application (2021-2026) Table 55. Global Cas9 Nuclease Sales by Application (2021-2026) & (US$ Million) Table 56. Global Cas9 Nuclease Sales Market Share in Value by Application (2021-2026) Table 57. Global Cas9 Nuclease Price by Application (2021-2026) & (US$/Unit) Table 58. Global Cas9 Nuclease Sales by Application (2027-2032) & (K Units) Table 59. Global Cas9 Nuclease Sales Market Share in Volume by Application (2027-2032) Table 60. Global Cas9 Nuclease Sales by Application (2027-2032) & (US$ Million) Table 61. Global Cas9 Nuclease Sales Market Share in Value by Application (2027-2032) Table 62. Global Cas9 Nuclease Price by Application (2027-2032) & (US$/Unit) Table 63. North America Cas9 Nuclease Sales by Application (2021-2026) & (K Units) Table 64. North America Cas9 Nuclease Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Cas9 Nuclease Sales by Application (2021-2026) & (K Units) Table 66. Europe Cas9 Nuclease Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Cas9 Nuclease Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Cas9 Nuclease Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Cas9 Nuclease Sales by Application (2021-2026) & (K Units) Table 70. Latin America Cas9 Nuclease Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Cas9 Nuclease Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Cas9 Nuclease Sales by Application (2021-2026) & (US$ Million) Table 73. SBS Genetech Company Information Table 74. SBS Genetech Business Overview Table 75. SBS Genetech Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. SBS Genetech Cas9 Nuclease Product Portfolio Table 77. SBS Genetech Recent Development Table 78. Novoprotein Company Information Table 79. Novoprotein Business Overview Table 80. Novoprotein Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Novoprotein Cas9 Nuclease Product Portfolio Table 82. Novoprotein Recent Development Table 83. Agilent Company Information Table 84. Agilent Business Overview Table 85. Agilent Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Agilent Cas9 Nuclease Product Portfolio Table 87. Agilent Recent Development Table 88. Thermo Fisher Scientific Company Information Table 89. Thermo Fisher Scientific Business Overview Table 90. Thermo Fisher Scientific Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Thermo Fisher Scientific Cas9 Nuclease Product Portfolio Table 92. Thermo Fisher Scientific Recent Development Table 93. Stemcell Technologies Company Information Table 94. Stemcell Technologies Business Overview Table 95. Stemcell Technologies Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Stemcell Technologies Cas9 Nuclease Product Portfolio Table 97. Stemcell Technologies Recent Development Table 98. Sigma-Aldrich Company Information Table 99. Sigma-Aldrich Business Overview Table 100. Sigma-Aldrich Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Sigma-Aldrich Cas9 Nuclease Product Portfolio Table 102. Sigma-Aldrich Recent Development Table 103. OriGene Technologies Company Information Table 104. OriGene Technologies Business Overview Table 105. OriGene Technologies Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. OriGene Technologies Cas9 Nuclease Product Portfolio Table 107. OriGene Technologies Recent Development Table 108. Nippon Gene Company Information Table 109. Nippon Gene Business Overview Table 110. Nippon Gene Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Nippon Gene Cas9 Nuclease Product Portfolio Table 112. Nippon Gene Recent Development Table 113. New England Biolabs Company Information Table 114. New England Biolabs Business Overview Table 115. New England Biolabs Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. New England Biolabs Cas9 Nuclease Product Portfolio Table 117. New England Biolabs Recent Development Table 118. Kactus Company Information Table 119. Kactus Business Overview Table 120. Kactus Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Kactus Cas9 Nuclease Product Portfolio Table 122. Kactus Recent Development Table 123. Horizo​​n Discovery Company Information Table 124. Horizo​​n Discovery Business Overview Table 125. Horizo​​n Discovery Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Horizo​​n Discovery Cas9 Nuclease Product Portfolio Table 127. Horizo​​n Discovery Recent Development Table 128. GenScript Company Information Table 129. GenScript Business Overview Table 130. GenScript Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. GenScript Cas9 Nuclease Product Portfolio Table 132. GenScript Recent Development Table 133. Danaher Company Information Table 134. Danaher Business Overview Table 135. Danaher Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Danaher Cas9 Nuclease Product Portfolio Table 137. Danaher Recent Development Table 138. BPS Bioscience Company Information Table 139. BPS Bioscience Business Overview Table 140. BPS Bioscience Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. BPS Bioscience Cas9 Nuclease Product Portfolio Table 142. BPS Bioscience Recent Development Table 143. Applied Biological Materials Company Information Table 144. Applied Biological Materials Business Overview Table 145. Applied Biological Materials Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Applied Biological Materials Cas9 Nuclease Product Portfolio Table 147. Applied Biological Materials Recent Development Table 148. Abnova Company Information Table 149. Abnova Business Overview Table 150. Abnova Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Abnova Cas9 Nuclease Product Portfolio Table 152. Abnova Recent Development Table 153. North America Cas9 Nuclease Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. North America Cas9 Nuclease Sales by Country (2021-2026) & (K Units) Table 155. North America Cas9 Nuclease Sales Market Share by Country (2021-2026) Table 156. North America Cas9 Nuclease Sales Forecast by Country (2027-2032) & (K Units) Table 157. North America Cas9 Nuclease Sales Market Share Forecast by Country (2027-2032) Table 158. North America Cas9 Nuclease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. North America Cas9 Nuclease Market Size by Country (2021-2026) & (US$ Million) Table 160. North America Cas9 Nuclease Market Share by Country (2021-2026) Table 161. North America Cas9 Nuclease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. North America Cas9 Nuclease Market Share Forecast by Country (2027-2032) Table 163. Europe Cas9 Nuclease Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Europe Cas9 Nuclease Sales by Country (2021-2026) & (K Units) Table 165. Europe Cas9 Nuclease Sales Market Share by Country (2021-2026) Table 166. Europe Cas9 Nuclease Sales Forecast by Country (2027-2032) & (K Units) Table 167. Europe Cas9 Nuclease Sales Market Share Forecast by Country (2027-2032) Table 168. Europe Cas9 Nuclease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Europe Cas9 Nuclease Market Size by Country (2021-2026) & (US$ Million) Table 170. Europe Cas9 Nuclease Market Share by Country (2021-2026) Table 171. Europe Cas9 Nuclease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Europe Cas9 Nuclease Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Cas9 Nuclease Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Cas9 Nuclease Sales by Country (2021-2026) & (K Units) Table 175. Asia-Pacific Cas9 Nuclease Sales Market Share by Country (2021-2026) Table 176. Asia-Pacific Cas9 Nuclease Sales Forecast by Country (2027-2032) & (K Units) Table 177. Asia-Pacific Cas9 Nuclease Sales Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Cas9 Nuclease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Cas9 Nuclease Market Size by Country (2021-2026) & (US$ Million) Table 180. Asia-Pacific Cas9 Nuclease Market Share by Country (2021-2026) Table 181. Asia-Pacific Cas9 Nuclease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Asia-Pacific Cas9 Nuclease Market Share Forecast by Country (2027-2032) Table 183. Latin America Cas9 Nuclease Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 184. Latin America Cas9 Nuclease Sales by Country (2021-2026) & (K Units) Table 185. Latin America Cas9 Nuclease Sales Market Share by Country (2021-2026) Table 186. Latin America Cas9 Nuclease Sales Forecast by Country (2027-2032) & (K Units) Table 187. Latin America Cas9 Nuclease Sales Market Share Forecast by Country (2027-2032) Table 188. Latin America Cas9 Nuclease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Latin America Cas9 Nuclease Market Size by Country (2021-2026) & (US$ Million) Table 190. Latin America Cas9 Nuclease Market Share by Country (2021-2026) Table 191. Latin America Cas9 Nuclease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Latin America Cas9 Nuclease Market Share Forecast by Country (2027-2032) Table 193. Middle East and Africa Cas9 Nuclease Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 194. Middle East and Africa Cas9 Nuclease Sales by Country (2021-2026) & (K Units) Table 195. Middle East and Africa Cas9 Nuclease Sales Market Share by Country (2021-2026) Table 196. Middle East and Africa Cas9 Nuclease Sales Forecast by Country (2027-2032) & (K Units) Table 197. Middle East and Africa Cas9 Nuclease Sales Market Share Forecast by Country (2027-2032) Table 198. Middle East and Africa Cas9 Nuclease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Middle East and Africa Cas9 Nuclease Market Size by Country (2021-2026) & (US$ Million) Table 200. Middle East and Africa Cas9 Nuclease Market Share by Country (2021-2026) Table 201. Middle East and Africa Cas9 Nuclease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Middle East and Africa Cas9 Nuclease Market Share Forecast by Country (2027-2032) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Cas9 Nuclease Distributors List Table 206. Cas9 Nuclease Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Cas9 Nuclease Image Figure 2. Global Cas9 Nuclease Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cas9 Nuclease Market Size (2021-2032) & (US$ Million) Figure 4. Global Cas9 Nuclease Sales (2021-2032) & (K Units) Figure 5. Cas9 mRNA Image Figure 6. Global Cas9 mRNA Sales YoY Growth (2021-2032) & (K Units) Figure 7. Cas9 Protein Image Figure 8. Global Cas9 Protein Sales YoY Growth (2021-2032) & (K Units) Figure 9. Cas9 Lentivirus Image Figure 10. Global Cas9 Lentivirus Sales YoY Growth (2021-2032) & (K Units) Figure 11. Cas9 Plasmid Image Figure 12. Global Cas9 Plasmid Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Cas9 Nuclease Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Cas9 Nuclease Market Share by Type 2025 VS 2032 Figure 15. North America Cas9 Nuclease Sales Market Share in Volume by Type in 2025 Figure 16. North America Cas9 Nuclease Sales Market Share in Value by Type in 2025 Figure 17. Europe Cas9 Nuclease Sales Market Share in Volume by Type in 2025 Figure 18. Europe Cas9 Nuclease Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Cas9 Nuclease Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Cas9 Nuclease Sales Market Share in Value by Type in 2025 Figure 21. Latin America Cas9 Nuclease Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Cas9 Nuclease Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Cas9 Nuclease Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Cas9 Nuclease Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Cas9 Nuclease Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Bioagriculture Image Figure 28. Global Bioagriculture Sales YoY Growth (2021-2032) & (K Units) Figure 29. Gene Therapy Image Figure 30. Global Gene Therapy Sales YoY Growth (2021-2032) & (K Units) Figure 31. Gene Editing Cell Line Construction Image Figure 32. Global Gene Editing Cell Line Construction Sales YoY Growth (2021-2032) & (K Units) Figure 33. Animal Models Image Figure 34. Global Animal Models Sales YoY Growth (2021-2032) & (K Units) Figure 35. Other Image Figure 36. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Cas9 Nuclease Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Cas9 Nuclease Market Share by Application 2025 VS 2032 Figure 39. North America Cas9 Nuclease Sales Market Share in Volume by Application in 2025 Figure 40. North America Cas9 Nuclease Sales Market Share in Value by Application in 2025 Figure 41. Europe Cas9 Nuclease Sales Market Share in Volume by Application in 2025 Figure 42. Europe Cas9 Nuclease Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Cas9 Nuclease Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Cas9 Nuclease Sales Market Share in Value by Application in 2025 Figure 45. Latin America Cas9 Nuclease Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Cas9 Nuclease Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Cas9 Nuclease Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Cas9 Nuclease Sales Market Share in Value by Application in 2025 Figure 49. North America Cas9 Nuclease Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Cas9 Nuclease Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Cas9 Nuclease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Cas9 Nuclease Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Cas9 Nuclease Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Cas9 Nuclease Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Cas9 Nuclease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Cas9 Nuclease Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Cas9 Nuclease Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Cas9 Nuclease Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Cas9 Nuclease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Cas9 Nuclease Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Cas9 Nuclease Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Cas9 Nuclease Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Cas9 Nuclease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Cas9 Nuclease Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Cas9 Nuclease Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Cas9 Nuclease Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Cas9 Nuclease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Cas9 Nuclease Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Cas9 Nuclease Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Cas9 Nuclease Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Cas9 mRNA
  • Cas9 Protein
  • Cas9 Lentivirus
  • Cas9 Plasmid
Applications
  • Bioagriculture
  • Gene Therapy
  • Gene Editing Cell Line Construction
  • Animal Models
  • Other
Companies covered
  • SBS Genetech
  • Novoprotein
  • Agilent
  • Thermo Fisher Scientific
  • Stemcell Technologies
  • Sigma-Aldrich
  • OriGene Technologies
  • Nippon Gene
  • New England Biolabs
  • Kactus
  • Horizo​​n Discovery
  • GenScript
  • Danaher
  • BPS Bioscience
  • Applied Biological Materials
  • Abnova

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cas9 Nuclease Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cas9 Nuclease Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cas9 Nuclease Market by Type
  6. 1.3.1 Cas9 mRNA
  7. 1.3.2 Cas9 Protein
  8. 1.3.3 Cas9 Lentivirus
  9. 1.3.4 Cas9 Plasmid
  10. 1.4 Global Cas9 Nuclease Market Size by Type
  11. 1.4.1 Global Cas9 Nuclease Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Cas9 Nuclease Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Cas9 Nuclease Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Cas9 Nuclease Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Cas9 Nuclease Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Cas9 Nuclease Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Cas9 Nuclease Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Cas9 Nuclease Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cas9 Nuclease Industry Trends
  2. 2.2 Cas9 Nuclease Industry Drivers
  3. 2.3 Cas9 Nuclease Industry Opportunities and Challenges
  4. 2.4 Cas9 Nuclease Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cas9 Nuclease Revenue (2021-2026)
  2. 3.2 Global Top Players by Cas9 Nuclease Sales (2021-2026)
  3. 3.3 Global Top Players by Cas9 Nuclease Price (2021-2026)
  4. 3.4 Global Cas9 Nuclease Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cas9 Nuclease Major Company Production Sites & Headquarters
  6. 3.6 Global Cas9 Nuclease Company, Product Type & Application
  7. 3.7 Global Cas9 Nuclease Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cas9 Nuclease Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cas9 Nuclease Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cas9 Nuclease Tier 1, Tier 2, and Tier 3
4 Cas9 Nuclease Regional Status and Outlook
  1. 4.1 Global Cas9 Nuclease Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cas9 Nuclease Historic Market Size by Region
  3. 4.2.1 Global Cas9 Nuclease Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cas9 Nuclease Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cas9 Nuclease Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cas9 Nuclease Forecasted Market Size by Region
  7. 4.3.1 Global Cas9 Nuclease Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cas9 Nuclease Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cas9 Nuclease Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cas9 Nuclease by Application
  1. 5.1 Cas9 Nuclease Market by Application
  2. 5.1.1 Bioagriculture
  3. 5.1.2 Gene Therapy
  4. 5.1.3 Gene Editing Cell Line Construction
  5. 5.1.4 Animal Models
  6. 5.1.5 Other
  7. 5.2 Global Cas9 Nuclease Market Size by Application
  8. 5.2.1 Global Cas9 Nuclease Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Cas9 Nuclease Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Cas9 Nuclease Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Cas9 Nuclease Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Cas9 Nuclease Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Cas9 Nuclease Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Cas9 Nuclease Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Cas9 Nuclease Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 SBS Genetech
  2. 6.1.1 SBS Genetech Company Information
  3. 6.1.2 SBS Genetech Business Overview
  4. 6.1.3 SBS Genetech Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 SBS Genetech Cas9 Nuclease Product Portfolio
  6. 6.1.5 SBS Genetech Recent Developments
  7. 6.2 Novoprotein
  8. 6.2.1 Novoprotein Company Information
  9. 6.2.2 Novoprotein Business Overview
  10. 6.2.3 Novoprotein Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novoprotein Cas9 Nuclease Product Portfolio
  12. 6.2.5 Novoprotein Recent Developments
  13. 6.3 Agilent
  14. 6.3.1 Agilent Company Information
  15. 6.3.2 Agilent Business Overview
  16. 6.3.3 Agilent Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Agilent Cas9 Nuclease Product Portfolio
  18. 6.3.5 Agilent Recent Developments
  19. 6.4 Thermo Fisher Scientific
  20. 6.4.1 Thermo Fisher Scientific Company Information
  21. 6.4.2 Thermo Fisher Scientific Business Overview
  22. 6.4.3 Thermo Fisher Scientific Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Thermo Fisher Scientific Cas9 Nuclease Product Portfolio
  24. 6.4.5 Thermo Fisher Scientific Recent Developments
  25. 6.5 Stemcell Technologies
  26. 6.5.1 Stemcell Technologies Company Information
  27. 6.5.2 Stemcell Technologies Business Overview
  28. 6.5.3 Stemcell Technologies Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Stemcell Technologies Cas9 Nuclease Product Portfolio
  30. 6.5.5 Stemcell Technologies Recent Developments
  31. 6.6 Sigma-Aldrich
  32. 6.6.1 Sigma-Aldrich Company Information
  33. 6.6.2 Sigma-Aldrich Business Overview
  34. 6.6.3 Sigma-Aldrich Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sigma-Aldrich Cas9 Nuclease Product Portfolio
  36. 6.6.5 Sigma-Aldrich Recent Developments
  37. 6.7 OriGene Technologies
  38. 6.7.1 OriGene Technologies Company Information
  39. 6.7.2 OriGene Technologies Business Overview
  40. 6.7.3 OriGene Technologies Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 OriGene Technologies Cas9 Nuclease Product Portfolio
  42. 6.7.5 OriGene Technologies Recent Developments
  43. 6.8 Nippon Gene
  44. 6.8.1 Nippon Gene Company Information
  45. 6.8.2 Nippon Gene Business Overview
  46. 6.8.3 Nippon Gene Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Nippon Gene Cas9 Nuclease Product Portfolio
  48. 6.8.5 Nippon Gene Recent Developments
  49. 6.9 New England Biolabs
  50. 6.9.1 New England Biolabs Company Information
  51. 6.9.2 New England Biolabs Business Overview
  52. 6.9.3 New England Biolabs Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 New England Biolabs Cas9 Nuclease Product Portfolio
  54. 6.9.5 New England Biolabs Recent Developments
  55. 6.10 Kactus
  56. 6.10.1 Kactus Company Information
  57. 6.10.2 Kactus Business Overview
  58. 6.10.3 Kactus Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Kactus Cas9 Nuclease Product Portfolio
  60. 6.10.5 Kactus Recent Developments
  61. 6.11 Horizo​​n Discovery
  62. 6.11.1 Horizo​​n Discovery Company Information
  63. 6.11.2 Horizo​​n Discovery Business Overview
  64. 6.11.3 Horizo​​n Discovery Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Horizo​​n Discovery Cas9 Nuclease Product Portfolio
  66. 6.11.5 Horizo​​n Discovery Recent Developments
  67. 6.12 GenScript
  68. 6.12.1 GenScript Company Information
  69. 6.12.2 GenScript Business Overview
  70. 6.12.3 GenScript Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 GenScript Cas9 Nuclease Product Portfolio
  72. 6.12.5 GenScript Recent Developments
  73. 6.13 Danaher
  74. 6.13.1 Danaher Company Information
  75. 6.13.2 Danaher Business Overview
  76. 6.13.3 Danaher Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Danaher Cas9 Nuclease Product Portfolio
  78. 6.13.5 Danaher Recent Developments
  79. 6.14 BPS Bioscience
  80. 6.14.1 BPS Bioscience Company Information
  81. 6.14.2 BPS Bioscience Business Overview
  82. 6.14.3 BPS Bioscience Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 BPS Bioscience Cas9 Nuclease Product Portfolio
  84. 6.14.5 BPS Bioscience Recent Developments
  85. 6.15 Applied Biological Materials
  86. 6.15.1 Applied Biological Materials Company Information
  87. 6.15.2 Applied Biological Materials Business Overview
  88. 6.15.3 Applied Biological Materials Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Applied Biological Materials Cas9 Nuclease Product Portfolio
  90. 6.15.5 Applied Biological Materials Recent Developments
  91. 6.16 Abnova
  92. 6.16.1 Abnova Company Information
  93. 6.16.2 Abnova Business Overview
  94. 6.16.3 Abnova Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Abnova Cas9 Nuclease Product Portfolio
  96. 6.16.5 Abnova Recent Developments
7 North America by Country
  1. 7.1 North America Cas9 Nuclease Sales by Country
  2. 7.1.1 North America Cas9 Nuclease Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cas9 Nuclease Sales by Country (2021-2026)
  4. 7.1.3 North America Cas9 Nuclease Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cas9 Nuclease Market Size by Country
  6. 7.2.1 North America Cas9 Nuclease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cas9 Nuclease Market Size by Country (2021-2026)
  8. 7.2.3 North America Cas9 Nuclease Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cas9 Nuclease Sales by Country
  2. 8.1.1 Europe Cas9 Nuclease Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cas9 Nuclease Sales by Country (2021-2026)
  4. 8.1.3 Europe Cas9 Nuclease Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cas9 Nuclease Market Size by Country
  6. 8.2.1 Europe Cas9 Nuclease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cas9 Nuclease Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cas9 Nuclease Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cas9 Nuclease Sales by Country
  2. 9.1.1 Asia-Pacific Cas9 Nuclease Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cas9 Nuclease Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cas9 Nuclease Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cas9 Nuclease Market Size by Country
  6. 9.2.1 Asia-Pacific Cas9 Nuclease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cas9 Nuclease Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cas9 Nuclease Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cas9 Nuclease Sales by Country
  2. 10.1.1 South America Cas9 Nuclease Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cas9 Nuclease Sales by Country (2021-2026)
  4. 10.1.3 South America Cas9 Nuclease Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cas9 Nuclease Market Size by Country
  6. 10.2.1 South America Cas9 Nuclease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cas9 Nuclease Market Size by Country (2021-2026)
  8. 10.2.3 South America Cas9 Nuclease Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cas9 Nuclease Sales by Country
  2. 11.1.1 Middle East and Africa Cas9 Nuclease Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cas9 Nuclease Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cas9 Nuclease Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cas9 Nuclease Market Size by Country
  6. 11.2.1 Middle East and Africa Cas9 Nuclease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cas9 Nuclease Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cas9 Nuclease Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cas9 Nuclease Value Chain Analysis
  2. 12.1.1 Cas9 Nuclease Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cas9 Nuclease Production Mode & Process
  7. 12.2 Cas9 Nuclease Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cas9 Nuclease Distributors
  10. 12.2.3 Cas9 Nuclease Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst